“Vircell” CYTOMEGALOVIRUS VIRCLIA IgM MONOTEST - Taiwan Registration 7fa61e5a95e4776685aa1a33ef26572c
Access comprehensive regulatory information for “Vircell” CYTOMEGALOVIRUS VIRCLIA IgM MONOTEST in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7fa61e5a95e4776685aa1a33ef26572c and manufactured by VIRCELL, S.L. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
7fa61e5a95e4776685aa1a33ef26572c
Ministry of Health Medical Device Import No. 032151
DHA05603215102
Product Details
This product is an indirect chemiluminescent immunoassay (CLIA) reagent, combined with Thunderbolt Immunoassay Analyzer, to qualitatively detect anti-cytomegalovirus IgM antibodies in human plasma.
C Immunology and microbiology devices
C3175 CMV serum reagent
Imported from abroad
Dates and Status
Jan 25, 2019
Jan 25, 2024

